Olopatadine Hydrochloride 60505-6221
Product NDC
60505-6221- Manufacturer
- Apotex Corp.
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- October 6, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA078350
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 1 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(1)
1 BOTTLE, PLASTIC in 1 CARTON (60505-6221-0) / 5 mL in 1 BOTTLE, PLASTIC